why choose us

First received: March 20, 2023

Clinical Trial: Deucravacitinib in PG

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Pyoderma Gangrenosum

Study Type: INTERVENTIONAL


Official Title: Novel Treatment of Pyoderma Gangrenosum With Deucravacitinib

Brief Summary: The main goal of this study is to see if the study drug called "Deucravacitinib" is safe and effective in treating people with pyoderma gangrenosum (PG).

Read more